Starting weight plays a role
Regular diabetes reviews typically every 36 monthsare essential for monitoring HbA1c, renal function, cardiovascular risk factors, and medication tolerability
Patients receive the same quality control as brand-name medications at a lower cost
Jain MR, Giri SR, Bhoi B, Trivedi C, Rath A, Rathod R, Ranvir R, Kadam S, Patel H, Swain P, Roy SS, Das N, Karmakar E, Wahli W, Patel PR
This complication has been assessed with multiple systematic reviews with meta-analyses demonstrating that while there may be an increased risk of acute pancreatitis with the DPP-4 inhibitors, there is no clear association with GLP1-RAs 16